Status:
WITHDRAWN
Adenomyosis: Genomic Mechanisms and Biological Response
Lead Sponsor:
University of Texas Southwestern Medical Center
Conditions:
Adenomyosis
Abnormal Uterine Bleeding
Eligibility:
FEMALE
18-60 years
Brief Summary
Examination of genomic and biologic responses to LNG-IUS in patients with adenomyosis.
Detailed Description
Examination of genomic and biologic responses to LNG-IUS in patients with adenomyosis.
Eligibility Criteria
Inclusion
- Abnormal bleeding in the presence of Adenomyosis as demonstrated by MRI
Exclusion
- Other causes of abnormal bleeding such as fibroids, endometrial polyps, malignancy
- Presence of endometriosis
Key Trial Info
Start Date :
December 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03428854
Start Date
December 1 2020
End Date
October 1 2022
Last Update
February 2 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.